• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Ali Var, Turkey

    Ali Var, Turkey

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • David Hall, USA

    David Hall, USA

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Ann Nicol, USA

    Ann Nicol, USA

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Steve

    Steve

  • Mark Miller, UK

    Mark Miller, UK

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • David Watson, Scotland

    David Watson, Scotland

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Jack Buzby, USA

    Jack Buzby, USA

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Mike Cels, Canada

    Mike Cels, Canada

  • Alex, Argentina

    Alex, Argentina

  • David Solomon, UK

    David Solomon, UK

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Hollister

    Hollister
    hollister

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login